Paper30607331
The Impact of CRISPR-Cas System on Antiviral Therapy.
Bayat H and 4 others. Adv Pharm Bull, 2018. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. The Impact of CRISPR-Cas System on Antiviral Therapy. Papers, record 30607331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30607331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19141480 | Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. | Genes Dev | 2008 | https://conductscience.org/library/papers/19141480 | PubMed |
| 2 | 24927590 | Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/24927590 | PubMed |
| 3 | 25049410 | RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25049410 | PubMed |
| 4 | 25136604 | Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/25136604 | PubMed |
| 5 | 25157128 | RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25157128 | PubMed |
| 6 | 25517468 | Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. | Cell Stem Cell | 2014 | https://conductscience.org/library/papers/25517468 | PubMed |
| 7 | 25553515 | Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease. | Virology | 2015 | https://conductscience.org/library/papers/25553515 | PubMed |
| 8 | 25565864 | Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells. | Onco Targets Ther | 2015 | https://conductscience.org/library/papers/25565864 | PubMed |
| 9 | 25643054 | A split-Cas9 architecture for inducible genome editing and transcription modulation. | Nat Biotechnol | 2015 | https://conductscience.org/library/papers/25643054 | PubMed |
| 10 | 25759096 | Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment. | Virology | 2015 | https://conductscience.org/library/papers/25759096 | PubMed |
| 11 | 25904148 | Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome. | J Gen Virol | 2015 | https://conductscience.org/library/papers/25904148 | PubMed |
| 12 | 25918406 | Cas9-mediated targeting of viral RNA in eukaryotic cells. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/25918406 | PubMed |
| 13 | 26035283 | CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus. | Sci Rep | 2015 | https://conductscience.org/library/papers/26035283 | PubMed |
| 14 | 26190106 | A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death. | Cell Rep | 2015 | https://conductscience.org/library/papers/26190106 | PubMed |
| 15 | 26285145 | HTLV-1 Tax Stimulates Ubiquitin E3 Ligase, Ring Finger Protein 8, to Assemble Lysine 63-Linked Polyubiquitin Chains for TAK1 and IKK Activation. | PLoS Pathog | 2015 | https://conductscience.org/library/papers/26285145 | PubMed |
| 16 | 26310292 | Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing. | Angew Chem Int Ed Engl | 2015 | https://conductscience.org/library/papers/26310292 | PubMed |
| 17 | 26334116 | CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X. | Sci Rep | 2015 | https://conductscience.org/library/papers/26334116 | PubMed |
| 18 | 26336974 | Engineered Viruses as Genome Editing Devices. | Mol Ther | 2016 | https://conductscience.org/library/papers/26336974 | PubMed |
| 19 | 26360417 | CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection. | PLoS One | 2015 | https://conductscience.org/library/papers/26360417 | PubMed |
| 20 | 26361997 | Inhibition of hepatitis C virus RNA replication by ISG15 does not require its conjugation to protein substrates by the HERC5 E3 ligase. | J Gen Virol | 2015 | https://conductscience.org/library/papers/26361997 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42610144 | AI-driven CRISPR strategies in breast cancer: Organoid modeling, adaptive editing, and precision delivery. | Iran J Basic Med Sci | 2026 | https://conductscience.org/library/papers/42610144 | PubMed |
| 40833724 | Advancements in CRISPR-Cas Systems for Genome Editing towards Eradication of Human Microbial Pathogens. | Mol Biotechnol | 2026 | https://conductscience.org/library/papers/40833724 | PubMed |
| 38273037 | CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from NT2 cells. | Sci Rep | 2024 | https://conductscience.org/library/papers/38273037 | PubMed |
| 38211734 | Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications. | Virus Res | 2024 | https://conductscience.org/library/papers/38211734 | PubMed |
| 37486521 | CRISPR Libraries and Whole-Genome Screening to Identify Essential Factors for Viral Infections. | Adv Exp Med Biol | 2023 | https://conductscience.org/library/papers/37486521 | PubMed |
| 35975201 | Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems. | Bioimpacts | 2022 | https://conductscience.org/library/papers/35975201 | PubMed |
| 35857175 | The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/35857175 | PubMed |
| 35269270 | Anti-COVID-19 Nanomaterials: Directions to Improve Prevention, Diagnosis, and Treatment. | Nanomaterials (Basel) | 2022 | https://conductscience.org/library/papers/35269270 | PubMed |
| 35228065 | Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35228065 | PubMed |
| 34768751 | Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34768751 | PubMed |
| 34542686 | CRISPR detectives against SARS-CoV-2: a major setback against COVID-19 blowout. | Appl Microbiol Biotechnol | 2021 | https://conductscience.org/library/papers/34542686 | PubMed |
| 34525746 | Viral outbreaks detection and surveillance using wastewater-based epidemiology, viral air sampling, and machine learning techniques: A comprehensive review and outlook. | Sci Total Environ | 2022 | https://conductscience.org/library/papers/34525746 | PubMed |
| 34175366 | Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies. | J Control Release | 2021 | https://conductscience.org/library/papers/34175366 | PubMed |
| 33670247 | Oligonucleotide-Based Approaches to Inhibit Dengue Virus Replication. | Molecules | 2021 | https://conductscience.org/library/papers/33670247 | PubMed |
| 33330126 | Application of CRISPR/Cas9 in Understanding Avian Viruses and Developing Poultry Vaccines. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/33330126 | PubMed |
| 33309323 | Nucleic Acid-Based Technologies Targeting Coronaviruses. | Trends Biochem Sci | 2021 | https://conductscience.org/library/papers/33309323 | PubMed |
| 33251158 | CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/33251158 | PubMed |
| 33005303 | CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy. | Comput Struct Biotechnol J | 2020 | https://conductscience.org/library/papers/33005303 | PubMed |
| 31512166 | A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System. | J Neuroimmune Pharmacol | 2019 | https://conductscience.org/library/papers/31512166 | PubMed |
| 30704043 | Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology. | Viruses | 2019 | https://conductscience.org/library/papers/30704043 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30607331
GET https://conductscience.org/api/papers/v1/30607331/references?page=2